3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
264
INDUSTRY
105
OTHER_GOV
13
NIH
13
NETWORK
2
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
49
Prostatic Neoplasms
38
Carcinoma, Non-Small-Cell Lung
28
Neoplasms
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Multiple Myeloma
22
Lymphoma
21
Leukemia, Myeloid, Acute
17
Colorectal Neoplasms
17
Melanoma
15
Lung Neoplasms
13
Hodgkin Disease
11
Brain Neoplasms
11
Medulloblastoma
10
Lymphoma, Non-Hodgkin
10
HIV Infections
10
Glioblastoma
10
Squamous Cell Carcinoma of Head and Neck
9
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Leukemia, Biphenotypic, Acute
9
Leukemia
9
Head and Neck Neoplasms
9
Neuroblastoma
8
Hematologic Neoplasms
8
Ependymoma
8
Glioma
7
Carcinoma, Renal Cell
7
Astrocytoma
7
Wilms Tumor
6
Interventions
durvalumab
1
Oxaliplatin
1
Lithium
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Esophageal Neoplasms
×
1 year
×
Clear all
NCT06290505
2026-05-08
PALEO
Australasian Gastro-Intestinal Trials Group
Phase 2
Recruiting
54 enrolled
NCT03153280
2025-07-08
Lithium
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled